Key facts
- This page summarizes Israel Maxx Abramowitz's Form 3/A - Amendment filing for Pasithea Therapeutics Corp. (KTTA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Oct 2021, 16:09.
Key filing fact
Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
This Form 3 was originally and incorrectly filed to disclose Israel Maxx Abramowitz as a 10% holder, specifically owning 1,051,575 shares of Common Stock through Epic Capital Inc. ("Epic"). At the time this Form 3 was originally filed, Mr. Abramowitz was the President and CEO of Epic and had sole voting and investment control with respect to the shares held by Epic. As such, Mr. Abramowitz may have be deemed to beneficially own the shares held directly by Epic. At this time, the 1,051,575 shares of Common Stock held by Epic represent less than 10% of the Common Stock. This amended Form 3/A discloses that Mr. Abramowitz is not a 10% holder.